These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
567 related articles for article (PubMed ID: 18441325)
1. Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. Bourguignon LY; Peyrollier K; Xia W; Gilad E J Biol Chem; 2008 Jun; 283(25):17635-51. PubMed ID: 18441325 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292 [TBL] [Abstract][Full Text] [Related]
3. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Bourguignon LY; Earle C; Wong G; Spevak CC; Krueger K Oncogene; 2012 Jan; 31(2):149-60. PubMed ID: 21685938 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. Bourguignon LYW; Xia W; Wong G J Biol Chem; 2009 Jan; 284(5):2657-2671. PubMed ID: 19047049 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells. Bourguignon LY; Peyrollier K; Gilad E; Brightman A J Biol Chem; 2007 Jan; 282(2):1265-80. PubMed ID: 17092940 [TBL] [Abstract][Full Text] [Related]
6. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. Bourguignon LY; Wong G; Earle C; Chen L J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005 [TBL] [Abstract][Full Text] [Related]
7. Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of Kaempferol in synergism with Verapamil. Nandi SK; Roychowdhury T; Chattopadhyay S; Basu S; Chatterjee K; Choudhury P; Banerjee N; Saha P; Mukhopadhyay S; Mukhopadhyay A; Bhattacharya R Toxicol Appl Pharmacol; 2022 Feb; 437():115887. PubMed ID: 35063459 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression. Bourguignon LY; Gilad E; Rothman K; Peyrollier K J Biol Chem; 2005 Mar; 280(12):11961-72. PubMed ID: 15655247 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787 [TBL] [Abstract][Full Text] [Related]
10. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. Bourguignon LY; Gilad E; Peyrollier K J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932 [TBL] [Abstract][Full Text] [Related]
11. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. Bourguignon LY; Zhu H; Shao L; Chen YW J Biol Chem; 2001 Mar; 276(10):7327-36. PubMed ID: 11084024 [TBL] [Abstract][Full Text] [Related]
12. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265 [TBL] [Abstract][Full Text] [Related]
13. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. Bourguignon LY; Singleton PA; Zhu H; Zhou B J Biol Chem; 2002 Oct; 277(42):39703-12. PubMed ID: 12145287 [TBL] [Abstract][Full Text] [Related]
14. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells. Bourguignon LYW; Earle C; Shiina M Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080 [TBL] [Abstract][Full Text] [Related]
15. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression. Bourguignon LY; Shiina M; Li JJ Adv Cancer Res; 2014; 123():255-75. PubMed ID: 25081533 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. Bourguignon LY; Singleton PA; Zhu H; Diedrich F J Biol Chem; 2003 Aug; 278(32):29420-34. PubMed ID: 12748184 [TBL] [Abstract][Full Text] [Related]